2011•Diabetes Research and Clinical PracticeRequires access

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Takashi Nomiyama, Yuko Akehi, Hiromasa Takenoshita, Ryoko Nagaishi, Yuichi Terawaki, H. Nagasako, Tadachika Kudo, Takehiko Kodera, Kunihisa Kobayashi, Hidenori Urata, Toshihiko Yanase

Open publisher page 53 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Sitagliptin, Medicine, Dipeptidyl peptidase-4 inhibitor, Dipeptidyl peptidase-4, Type 2 diabetes, Sitagliptin Phosphate, Diabetes mellitus, Internal medicine